Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'nsc 146109 hydrochloride'

Search results for: 'nsc 146109 hydrochloride'

Items 31-40 of 51

Page
per page
  1. 2,3-DCPE hydrochloride
    A4447 2,3-DCPE hydrochloride
    Target: Apoptosis Inducers
    Summary: Bcl-XL protein expression downregulator
      <30.06 mg/mL
  2. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  3. 5-Iodotubercidin
    A3125 5-Iodotubercidin
    Target: Adenosine Kinases
    Summary: Adenosine kinase inhibitor,potent
      ≥83 mg/mL
  4. SRT1720 HCl
    A4180 SRT1720 HCl
     3 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator
      ≥25.3 mg/mL
  5. Zebularine
    A1915 Zebularine
     1 Citation
    Target: DNA Methyltransferases|Cytidine deaminases
    Summary: DNA methylation inhibitor
      insoluble in EtOH; ≥50.7 mg/mL
  6. TBB
    A3861 TBB
     1 Citation
    Target: CK2
    Summary: Casein kinase-2 (CK2) inhibitor
      insoluble in H2O; ≥159.2 mg/mL
  7. Phloretin
    A3723 Phloretin
    Target: SGLT
    Summary: A dihydrochalcone found in apple
      insoluble in H2O; ≥105 mg/mL
  8. DMXAA (Vadimezan)
    A8233 DMXAA (Vadimezan)
     2 Citation
    Target: DT-diaphorases
    Summary: Tumnor vascular disrupting agent, apoptosis inducer
      insoluble in H2O; insoluble in EtOH; ≥14.1 mg/mL
  9. 3-Deazaneplanocin,DZNep
    A1905 3-Deazaneplanocin,DZNep
     6 Citation
    Target: Hydrolase
    Summary: S-adenosylhomocysteine and EZH2 inhibitor
      insoluble in EtOH; ≥17.07 mg/mL
  10. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL

Items 31-40 of 51

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Proteasome 1 item
  3. Histone Deacetylases (HDACs) 1 item
  4. Aurora Kinases 1 item
  5. EZH2 1 item
  6. MMP 1 item
  7. Thymidine Phosphorylases 1 item
  8. DT-diaphorases 1 item
  9. GSK-3 1 item
  10. Phosphodiesterases (PDEs) 2item
  11. Hydrolase 1 item
  12. p38 1 item
  13. Nrf2 1 item
  14. GABAB Receptors 1 item
  15. Sir2-like Family Deacetylases (Sirtuins) 1 item
  16. Deubiquitinating enzymes (DUBs) 1 item
  17. STAT 1 item
  18. EGFR 2item
  19. FAK 1 item
  20. Syk 1 item
  21. HSP90 1 item
  22. AMPK 1 item
  23. Adenosine Kinases 1 item
  24. DNA Methyltransferases 1 item
  25. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  26. SGLT 1 item
  27. Pyk2 1 item
  28. 5-HT2 Receptors 2item
  29. S1P receptors 1 item
  30. Myosin light chain kinases (MLCKs) 1 item
  31. 5-HT3 Receptors 1 item
  32. Angiotensin-Converting Enzymes (ACEs) 1 item
  33. CK2 1 item
  34. Squalene epoxidases 2item
  35. Nampt 1 item
  36. Glutamate (Metabotropic) Group I Receptors 1 item
  37. Apoptosis Inducers 1 item
  38. AChE 1 item
  39. Cytidine deaminases 1 item
  40. IKK 1 item
  41. Calcium-Sensing Receptors (CaSRs) 1 item
  42. CRF1 Receptors 1 item
Reported Experiments
  1. Animal Experiments 48item
  2. Cell Experiments 39item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 3item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 5item
  6. Cancer 23item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 4item
  9. Colorectal Cancer 3item
  10. Diabetes 1 item
  11. Erectile Dysfunction 1 item
  12. Glioblastoma 2item
  13. Glioma 2item
  14. Hepatocellular Carcinoma 2item
  15. Inflammatory Diseases 2item
  16. Leukemia 1 item
  17. Liver Cancer 1 item
  18. Lung Cancer 4item
  19. Mantle Cell Lymphoma 1 item
  20. Melanoma 1 item
  21. Multidrug Resistance Studies 1 item
  22. Multiple Myeloma 3item
  23. Narcolepsy 1 item
  24. Non-small Cell Lung Cancer 1 item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 4item
  27. Schizophrenia 1 item
  28. Squamous Cell Carcinoma 1 item
  29. Type 2 Diabetes 1 item